Eads & Heald Wealth Management Purchases 308 Shares of Mettler-Toledo International, Inc. (NYSE:MTD)

Eads & Heald Wealth Management lifted its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 77.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 708 shares of the medical instruments supplier's stock after acquiring an additional 308 shares during the period. Eads & Heald Wealth Management's holdings in Mettler-Toledo International were worth $836,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. SBI Securities Co. Ltd. bought a new stake in Mettler-Toledo International in the 4th quarter worth approximately $33,000. Edmond DE Rothschild Holding S.A. bought a new stake in Mettler-Toledo International in the 4th quarter worth approximately $44,000. Golden State Wealth Management LLC grew its position in Mettler-Toledo International by 583.3% in the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock worth $48,000 after purchasing an additional 35 shares during the period. Menard Financial Group LLC bought a new stake in Mettler-Toledo International in the 4th quarter worth approximately $67,000. Finally, Blue Trust Inc. grew its position in Mettler-Toledo International by 520.0% in the 1st quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock worth $73,000 after purchasing an additional 52 shares during the period. Institutional investors own 95.07% of the company's stock.

Mettler-Toledo International Stock Performance

MTD opened at $1,184.40 on Monday. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,546.93. The firm's fifty day moving average is $1,133.98 and its 200 day moving average is $1,197.21. The stock has a market cap of $24.61 billion, a price-to-earnings ratio of 29.54, a price-to-earnings-growth ratio of 3.64 and a beta of 1.38.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share for the quarter, beating analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.17% and a negative return on equity of 556.22%. The company had revenue of $883.74 million for the quarter, compared to analysts' expectations of $876.61 million. During the same quarter in the previous year, the company earned $8.89 EPS. Mettler-Toledo International's revenue for the quarter was down 4.6% on a year-over-year basis. On average, equities research analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Insider Activity at Mettler-Toledo International

In related news, Director Michael A. Kelly sold 1,062 shares of Mettler-Toledo International stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the transaction, the director now owns 120 shares in the company, valued at approximately $139,191.60. The trade was a 89.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.77% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. Citigroup raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price for the company in a research report on Monday, April 7th. Jefferies Financial Group raised shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and cut their target price for the stock from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. Barclays began coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 target price for the company. Robert W. Baird dropped their price target on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 22nd. Finally, Bank of America lifted their price target on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research note on Thursday. Eight analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, Mettler-Toledo International presently has an average rating of "Hold" and a consensus target price of $1,300.36.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.